David Kylhammar (Former)
1 – 20 of 20
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals—a Swedish population-based study
(
- Contribution to journal › Article
- 2021
-
Mark
Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival
(
- Contribution to journal › Article
-
Mark
The ratio FEV1/FVC and its association to respiratory symptoms—A Swedish general population study
(
- Contribution to journal › Article
- 2020
-
Mark
Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers : a cross-sectional study
(
- Contribution to journal › Article
- 2019
-
Mark
Pulmonary arterial hypertension : assessing risk to improve prognosis
(
- Contribution to journal › Article
-
Mark
Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008-2016
(
- Contribution to journal › Article
- 2018
-
Mark
Plasma l-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction
(
- Contribution to journal › Article
-
Mark
Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2017
-
Mark
Pulmonell hypertension vanligt vid kronisk lungsjukdom
(
- Contribution to journal › Article
-
Mark
The principal pathways involved in the in vivo modulation of hypoxic pulmonary vasoconstriction, pulmonary arterial remodelling and pulmonary hypertension
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Modulators of hypoxic pulmonary vasoconstriction and pulmonary hypertension. Implications for new treatment strategies.
2016)(
- Thesis › Doctoral thesis (compilation)
- 2014
-
Mark
Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
P2Y1 and P2Y12 receptors in hypoxia- and adenosine diphosphate-induced pulmonary vasoconstriction in vivo in the pig.
(
- Contribution to journal › Article
- 2012
-
Mark
Cyclooxygenase-2 inhibition and thromboxane A (2) receptor antagonism attenuate hypoxic pulmonary vasoconstriction in a porcine model.
(
- Contribution to journal › Article
-
Mark
Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia induced pulmonary vasoconstriction in a porcine model.
(
- Contribution to journal › Article
-
Mark
sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
(
- Contribution to journal › Article
-
Mark
Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model.
(
- Contribution to journal › Article
- 2010
-
Mark
The sGC stimulator BAY 41-8543 totally reverse hypoxia induced pulmonary hypertension
(
- Contribution to journal › Published meeting abstract
-
Mark
The thromboxane A2 receptor antagonist Daltroban counteracts acute hypoxic pulmonary vasoconstriction
(
- Contribution to journal › Published meeting abstract